kadmy / iStockphoto.com
Four generic companies have pushed a district court to dismiss competition allegations against them, stating that the latest amendments made by American Sales Company in a class action complaint are “purely cosmetic” and add no new factual allegations.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Teva, Sun Pharmaceutical, Actavis, Mylan, patent, generics, competition, antitrust, generic companies,